Autor/in Hanusch, C Becker, C 1 Denkert, C 1 Eggemann, H 1 Eidtmann, H 1 Fasching, P A 1 Higgs, B W 1 Holtrich, U 1 Huober, J 1 Jank, P 1 Karn, T 1 Kittel, K 1 Loibl, S 1 Rezai, M 1 Schrader, I 1 Sinn, B V 1 Sinn, H P 1 Tesch, H 1 Untch, M 1 Weber, K E 1 von Minckwitz, G 1 alle zeigenListe einklappen
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo Karn, T Denkert, C Weber, K E Holtrich, U Hanusch, C Sinn, B V Higgs, B W 2020 - Forschungsinformationssystem des UKE
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)† von Minckwitz, G Loibl, S Untch, M Eidtmann, H Rezai, M Fasching, P A Tesch, H 2014 - Forschungsinformationssystem des UKE
